Africa
Showing the single result
-
South Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Country Analysis – by Product (Embolic Agents and Support Devices), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders, and Others), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Other End Users)
$3,000.00 – $5,000.00 Select options